CARBOGEN AMCIS: Swissmedic inspection success highlights excellence at CARBOGEN AMCIS Vionnaz site
Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic inspection of its Vionnaz facility, reaffirming the site's compliance with high regulatory standards
Read full article »
CEO
CARBOGEN AMCIS is a provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries.
Read more